Liraglutide Lowers Risk for Cardiovascular Complications, Kidney Disease and Death in People with Type 2 Diabetes

American Diabetes Association logoNEW ORLEANS, June 13, 2016 /prnewswire usnewswire/ — Liraglutide, a sugar-reducing medication, hasbeen proven to securely and efficiently reduce the entire threat of coronary attack, swing or cardiovascular death among individuals with diabetes at high-risk for cardiovascular disease, according…

Leave a Reply

Your email address will not be published. Required fields are marked *